These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 11781819

  • 1. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells.
    Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, Yu D.
    Oncogene; 2001 Dec 06; 20(56):8066-74. PubMed ID: 11781819
    [Abstract] [Full Text] [Related]

  • 2. Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells.
    Tang FY, Chiang EP, Sun YC.
    J Nutr Biochem; 2008 May 06; 19(5):287-94. PubMed ID: 17651959
    [Abstract] [Full Text] [Related]

  • 3. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.
    Denkert C, Siegert A, Leclere A, Turzynski A, Hauptmann S.
    Clin Exp Metastasis; 2002 May 06; 19(1):79-85. PubMed ID: 11918086
    [Abstract] [Full Text] [Related]

  • 4. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ, Park IC, Hur JH, Kim MS, Lee HC, Woo SH, Lee KH, Rhee CH, Hong SI, Lee SH.
    J Neurosurg; 2002 Jul 06; 97(1):112-8. PubMed ID: 12134900
    [Abstract] [Full Text] [Related]

  • 5. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV, Sun Y, Westbrook L, Rentz SS, Manuvakhova M, Qu Z, Samuel S, Upshaw R, Cunningham A, Kern FG.
    Cancer Res; 2004 Jul 01; 64(13):4637-47. PubMed ID: 15231676
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.
    Simon C, Goepfert H, Boyd D.
    Cancer Res; 1998 Mar 15; 58(6):1135-9. PubMed ID: 9515796
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Protein tyrosine kinase and p38 MAP kinase pathways are involved in stimulation of matrix metalloproteinase-9 by TNF-alpha in human monocytes.
    Nguyen J, Gogusev J, Knapnougel P, Bauvois B.
    Immunol Lett; 2006 Jul 15; 106(1):34-41. PubMed ID: 16720051
    [Abstract] [Full Text] [Related]

  • 9. Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells.
    Denkert C, Koch I, Berger S, Köbel M, Siegert A, Hauptmann S.
    Cancer Lett; 2003 May 30; 195(1):101-9. PubMed ID: 12767518
    [Abstract] [Full Text] [Related]

  • 10. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH, Lin CC, Lin JK, Chen WJ.
    J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells.
    Puricelli L, Proietti CJ, Labriola L, Salatino M, Balañá ME, Aguirre Ghiso J, Lupu R, Pignataro OP, Charreau EH, Bal de Kier Joffé E, Elizalde PV.
    Int J Cancer; 2002 Aug 20; 100(6):642-53. PubMed ID: 12209601
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation.
    Simon C, Simon M, Vucelic G, Hicks MJ, Plinkert PK, Koitschev A, Zenner HP.
    Exp Cell Res; 2001 Dec 10; 271(2):344-55. PubMed ID: 11716547
    [Abstract] [Full Text] [Related]

  • 15. p38 MAP kinase mediates transforming-growth factor-β1-induced upregulation of matrix metalloproteinase-9 but not -2 in human brain pericytes.
    Takahashi Y, Maki T, Liang AC, Itoh K, Lok J, Osumi N, Arai K.
    Brain Res; 2014 Dec 17; 1593():1-8. PubMed ID: 25451097
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
    Lee KH, Hyun MS, Kim JR.
    Clin Exp Metastasis; 2003 Dec 17; 20(6):499-505. PubMed ID: 14598883
    [Abstract] [Full Text] [Related]

  • 18. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
    Ostrander JH, Daniel AR, Lofgren K, Kleer CG, Lange CA.
    Cancer Res; 2007 May 01; 67(9):4199-209. PubMed ID: 17483331
    [Abstract] [Full Text] [Related]

  • 19. Examination of the signal transduction pathways involved in matrix metalloproteinases-2 in human pulp cells.
    Huang FM, Yang SF, Hsieh YS, Liu CM, Yang LC, Chang YC.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Mar 01; 97(3):398-403. PubMed ID: 15024367
    [Abstract] [Full Text] [Related]

  • 20. Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.
    Thant AA, Nawa A, Kikkawa F, Ichigotani Y, Zhang Y, Sein TT, Amin AR, Hamaguchi M.
    Clin Exp Metastasis; 2000 Mar 01; 18(5):423-8. PubMed ID: 11467775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.